Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Oct'23
Oct'22
Oct'21
Oct'20
Oct'19
Oct'18
Oct'17
Net Sales
53.91
27.75
13.56
7.47
6.58
4.38
1.28
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
53.91
27.75
13.56
7.47
6.58
4.38
1.28
Raw Material Cost
41.69
22.14
10.06
6.32
5.25
3.59
2.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
18.84
14.86
9.06
0.00
0.00
0.00
1.87
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.82
6.50
1.39
0.61
0.13
0.27
0.18
Selling and Distribution Expenses
29.45
25.21
15.97
5.24
5.05
3.22
1.06
Other Expenses
-3.27
-2.14
-1.04
-0.06
-0.01
-0.03
-0.19
Total Expenditure (Excl Depreciation)
71.14
47.35
26.03
11.56
10.31
6.81
3.85
Operating Profit (PBDIT) excl Other Income
-17.2
-19.6
-12.5
-4.1
-3.7
-2.4
-2.6
Other Income
2.93
-1.09
0.23
0.20
0.26
0.15
0.05
Operating Profit (PBDIT)
-11.67
-19.28
-11.50
-3.47
-3.35
-2.24
-2.48
Interest
13.82
6.50
1.39
0.61
0.13
0.27
0.18
Exceptional Items
0.31
0.27
-0.61
-0.26
0.00
0.15
-1.80
Gross Profit (PBDT)
12.22
5.61
3.50
1.15
1.32
0.79
-1.38
Depreciation
2.63
1.42
0.74
0.42
0.14
0.04
0.04
Profit Before Tax
-27.81
-26.92
-14.23
-4.76
-3.62
-2.40
-4.50
Tax
0.00
-1.17
0.00
0.00
0.00
0.04
-0.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-27.81
-25.75
-14.23
-4.76
-3.62
-2.44
-3.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-27.81
-25.75
-14.23
-4.76
-3.62
-2.44
-3.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-27.81
-25.75
-14.23
-4.76
-3.62
-2.44
-3.62
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
-40.34
-17.85
2.05
3.07
-0.02
-1.37
-2.60
Earnings per share (EPS)
-0.32
-0.32
-0.2
-0.08
-0.07
-0.05
-0.08
Diluted Earnings per share
-0.32
-0.32
-0.2
-0.08
-0.07
-0.05
-0.08
Operating Profit Margin (Excl OI)
-31.96%
-70.66%
-92.0%
-54.73%
-56.82%
-55.42%
-201.06%
Gross Profit Margin
-46.71%
-91.92%
-99.51%
-58.06%
-52.91%
-53.76%
-349.11%
PAT Margin
-51.58%
-92.8%
-104.99%
-63.73%
-54.96%
-55.62%
-283.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Oct 2023 is 94.58% vs 103.68% in Oct 2022
Consolidate Net Profit
YoY Growth in year ended Oct 2023 is -8.17% vs -80.99% in Oct 2022
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Oct 2023 is 19.78% vs -55.56% in Oct 2022
Interest
YoY Growth in year ended Oct 2023 is 112.31% vs 364.29% in Oct 2022
Operating Profit Margin (Excl OI)
YoY Growth in year ended Oct 2023 has improved from Oct 2022
Compare Annual Results Of Valeo Pharma, Inc. With
Figures in Million
Consolidate Annual Results
Change(CAD)
Change(%)
Net Sales
53.91
4.79
49.12
1,025.47%
Other Operating Income
0.00
0.00
0.00
Total Operating income
53.91
4.79
49.12
1,025.47%
Raw Material Cost
41.69
2.91
38.78
1,332.65%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
18.84
0.83
18.01
2,169.88%
Power Cost
0
0
0.00
Manufacturing Expenses
13.82
0.01
13.81
138,100.00%
Selling and Distribution Expenses
29.45
1.74
27.71
1,592.53%
Other Expenses
-3.27
-0.08
-3.19
-3,987.50%
Total Expenditure (Excl Depreciation)
71.14
4.65
66.49
1,429.89%
Operating Profit (PBDIT) excl Other Income
-17.23
0.14
-17.37
-12,407.14%
Other Income
2.93
-0.04
2.97
7,425.00%
Operating Profit (PBDIT)
-11.67
0.55
-12.22
-2,221.82%
Interest
13.82
0.01
13.81
138,100.00%
Exceptional Items
0.31
-0.76
1.07
140.79%
Gross Profit (PBDT)
12.22
1.88
10.34
550.00%
Depreciation
2.63
0.45
2.18
484.44%
Profit Before Tax
-27.81
-0.67
-27.14
-4,050.75%
Tax
0.00
0.00
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-27.81
-0.67
-27.14
-4,050.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-27.81
-0.67
-27.14
-4,050.75%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-27.81
-0.67
-27.14
-4,050.75%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
-40.34
1.97
-42.31
-2,147.72%
Earnings per share (EPS)
-0.32
-0.01
-0.31
-3,100.00%
Diluted Earnings per share
-0.32
-0.01
-0.31
-3,100.00%
Operating Profit Margin (Excl OI)
-31.96%
2.91%
0.00
-34.87%
Gross Profit Margin
-46.71%
-4.57%
0.00
-42.14%
PAT Margin
-51.58%
-13.98%
0.00
-37.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5.39 Million
in Oct 2023Figures in Million
YoY Growth in year ended Oct 2023 is 94.58% vs 103.68% in Oct 2022
Annual - Consolidate Net Profit
Consolidate Net Profit -2.78 Million
in Oct 2023Figures in Million
YoY Growth in year ended Oct 2023 is -8.17% vs -80.99% in Oct 2022
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.46 Million
in Oct 2023Figures in Million
YoY Growth in year ended Oct 2023 is 19.78% vs -55.56% in Oct 2022
Annual - Interest
Interest 1.38 Million
in Oct 2023Figures in Million
YoY Growth in year ended Oct 2023 is 112.31% vs 364.29% in Oct 2022
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -31.96%
in Oct 2023Figures in %
YoY Growth in year ended Oct 2023 has improved from Oct 2022
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
